Therapeutic Options for Aggressive T-Cell Lymphomas Jennifer K. LueAnna KressJennifer E. Amengual B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (D Persky, Section Editor) 01 June 2017 Pages: 269 - 281
An Update on the Use of Immunotherapy in the Treatment of Lymphoma Thomas U. MarronMatko KalacJoshua Brody B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (D Persky, Section Editor) 22 July 2017 Pages: 282 - 289
Patterns of Care and Survival for Elderly Acute Myeloid Leukemia—Challenges and Opportunities Abhishek A. MangaonkarMrinal M. Patnaik Health Economics (N Khera, Section Editor) 31 May 2017 Pages: 290 - 299
Early Palliative Care for Patients with Hematologic Malignancies: Is It Really so Difficult to Achieve? Thomas W. LeBlancEric J. RoelandAreej El-Jawahri Health Economics (N Khera, Section Editor) 21 June 2017 Pages: 300 - 308
Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet? Sikander AilawadhiKirtipal BhatiaAsher Chanan-Khan Health Economics (N Khera, Section Editor) 19 June 2017 Pages: 309 - 316
Coordination of Care in Survivorship After Treatment of Hematological Malignancies—The Journey is Not Over Yet Catherine J. LeeLori S. Muffly Health Economics (N Khera, Section Editor) 22 May 2017 Pages: 317 - 323
Patient and Caregiver Adjustment to Hematopoietic Stem Cell Transplantation: a Systematic Review of Dyad-Based Studies Shelby LangerChristine LehaneJean Yi Health Economics (N Khera, Section Editor) 01 June 2017 Pages: 324 - 334
Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy Andrew D. FesnakPatrick J. HanleyBruce L. Levine CART and Immunotherapy (M Ruella, Section Editor) 31 July 2017 Pages: 335 - 343
Novel Immunotherapies for Multiple Myeloma Mattia D’AgostinoMario BoccadoroEric L. Smith CART and Immunotherapy (M Ruella, Section Editor) 18 August 2017 Pages: 344 - 357
Targeting Immune System Alterations in Hodgkin Lymphoma Natalie S. GroverBarbara Savoldo CART and Immunotherapy (M Ruella, Section Editor) 05 August 2017 Pages: 358 - 369
Chimeric Antigen Receptor Therapy in Acute Lymphoblastic Leukemia Clinical Practice Marlise R. LuskinDaniel J. DeAngelo Acute Lymphocytic Leukemias (K Ballen, Section Editor) 27 June 2017 Pages: 370 - 379